Targeted and non-targeted actions of anti-cancer drugs
- 1 January 1994
- journal article
- review article
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 34, 71-89
- https://doi.org/10.1016/0065-2571(94)90009-4
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Regulation of deoxycytidine kinase activity and inhibition by DFDCAdvances in Enzyme Regulation, 1993
- Methotrexate decreases thymidine kinase activityBiochemical and Biophysical Research Communications, 1992
- Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemiaAdvances in Enzyme Regulation, 1988
- Action of the active metabolites of tiazofurin and ribavirin on purified IMP dehydrogenaseBiochemistry, 1988
- Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurinBiochemical Pharmacology, 1988
- Salvage pathways as targets of chemotherapyAdvances in Enzyme Regulation, 1987
- Amphotericin B renders stationary phase hepatoma cells sensitive to dipyridamoleBiochemical and Biophysical Research Communications, 1986
- Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurinAdvances in Enzyme Regulation, 1984
- Studies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activityAdvances in Enzyme Regulation, 1983
- Nucleoside and Nucleotide Inhibitors of Inosine Monophosphate (IMP) Dehydrogenase as Potential Antitumor InhibitorsNucleosides and Nucleotides, 1982